BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 19858324)

  • 1. Identity of the elusive IgM Fc receptor (FcmuR) in humans.
    Kubagawa H; Oka S; Kubagawa Y; Torii I; Takayama E; Kang DW; Gartland GL; Bertoli LF; Mori H; Takatsu H; Kitamura T; Ohno H; Wang JY
    J Exp Med; 2009 Nov; 206(12):2779-93. PubMed ID: 19858324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of TOSO/FAIM3 as an Fc receptor for IgM.
    Shima H; Takatsu H; Fukuda S; Ohmae M; Hase K; Kubagawa H; Wang JY; Ohno H
    Int Immunol; 2010 Mar; 22(3):149-56. PubMed ID: 20042454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TOSO, the Fcmicro receptor, is highly expressed on chronic lymphocytic leukemia B cells, internalizes upon IgM binding, shuttles to the lysosome, and is downregulated in response to TLR activation.
    Vire B; David A; Wiestner A
    J Immunol; 2011 Oct; 187(8):4040-50. PubMed ID: 21908732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique ligand-binding property of the human IgM Fc receptor.
    Honjo K; Kubagawa Y; Kearney JF; Kubagawa H
    J Immunol; 2015 Feb; 194(4):1975-82. PubMed ID: 25601920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Roles of the IgM Fc Receptor in the Immune System.
    Kubagawa H; Honjo K; Ohkura N; Sakaguchi S; Radbruch A; Melchers F; Jani PK
    Front Immunol; 2019; 10():945. PubMed ID: 31130948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered Ig levels and antibody responses in mice deficient for the Fc receptor for IgM (FcμR).
    Honjo K; Kubagawa Y; Jones DM; Dizon B; Zhu Z; Ohno H; Izui S; Kearney JF; Kubagawa H
    Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15882-7. PubMed ID: 22984178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the IgM Fc Receptor in Immunity and Tolerance.
    Liu J; Wang Y; Xiong E; Hong R; Lu Q; Ohno H; Wang JY
    Front Immunol; 2019; 10():529. PubMed ID: 30967868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long elusive IgM Fc receptor, FcμR.
    Kubagawa H; Oka S; Kubagawa Y; Torii I; Takayama E; Kang DW; Jones D; Nishida N; Miyawaki T; Bertoli LF; Sanders SK; Honjo K
    J Clin Immunol; 2014 Jul; 34 Suppl 1(0 1):S35-45. PubMed ID: 24793544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fcμ receptor as a Costimulatory Molecule for T Cells.
    Meryk A; Pangrazzi L; Hagen M; Hatzmann F; Jenewein B; Jakic B; Hermann-Kleiter N; Baier G; Jylhävä J; Hurme M; Trieb K; Grubeck-Loebenstein B
    Cell Rep; 2019 Mar; 26(10):2681-2691.e5. PubMed ID: 30840890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing the fcμ receptor for potent and selective cytotoxic therapy of chronic lymphocytic leukemia.
    Vire B; Skarzynski M; Thomas JD; Nelson CG; David A; Aue G; Burke TR; Rader C; Wiestner A
    Cancer Res; 2014 Dec; 74(24):7510-7520. PubMed ID: 25344228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The old but new IgM Fc receptor (FcμR).
    Kubagawa H; Kubagawa Y; Jones D; Nasti TH; Walter MR; Honjo K
    Curr Top Microbiol Immunol; 2014; 382():3-28. PubMed ID: 25116093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping of the binding site for FcμR in human IgM-Fc.
    Nyamboya RA; Sutton BJ; Calvert RA
    Biochim Biophys Acta Proteins Proteom; 2020 Jan; 1868(1):140266. PubMed ID: 31449905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies specific for human IgM Fc receptor inhibit ligand-binding activity.
    Kubagawa Y; Honjo K; Kang DW; Kubagawa H
    Monoclon Antib Immunodiagn Immunother; 2014 Dec; 33(6):393-400. PubMed ID: 25545208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of the IgM Fc receptor in IgM homeostasis, B-cell survival, and humoral immune responses.
    Ouchida R; Mori H; Hase K; Takatsu H; Kurosaki T; Tokuhisa T; Ohno H; Wang JY
    Proc Natl Acad Sci U S A; 2012 Oct; 109(40):E2699-706. PubMed ID: 22988094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric antigen receptor T cells targeting Fc μ receptor selectively eliminate CLL cells while sparing healthy B cells.
    Faitschuk E; Hombach AA; Frenzel LP; Wendtner CM; Abken H
    Blood; 2016 Sep; 128(13):1711-22. PubMed ID: 27535994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pro-inflammatory role of Fcα/μR on marginal zone B cells in sepsis.
    Shibuya A; Honda SI; Shibuya K
    Int Immunol; 2017 Dec; 29(11):519-524. PubMed ID: 29281010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FcμR (Toso/Faim3) is not an inhibitor of Fas-mediated cell death in mouse T and B cells.
    Ouchida R; Mori H; Ohno H; Wang JY
    Blood; 2013 Mar; 121(12):2368-70. PubMed ID: 23520334
    [No Abstract]   [Full Text] [Related]  

  • 18. Structural basis for Fc receptor recognition of immunoglobulin M.
    Chen Q; Menon RP; Masino L; Tolar P; Rosenthal PB
    Nat Struct Mol Biol; 2023 Jul; 30(7):1033-1039. PubMed ID: 37095205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Mott cell formation linked with IgM Fc receptor (FcμR) deficiency.
    Mahmoudi Aliabadi P; Al-Qaisi K; Jani PK; Honjo K; Klemm U; Lee KH; Baumgarth N; Radbruch A; Melchers F; Kubagawa H
    Eur J Immunol; 2023 Jul; 53(7):e2250315. PubMed ID: 37098762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FcμR in human B cell subsets in primary selective IgM deficiency, and regulation of FcμR and production of natural IgM antibodies by IGIV.
    Gupta S; Agrawal S; Gollapudi S; Kubagawa H
    Hum Immunol; 2016 Dec; 77(12):1194-1201. PubMed ID: 27751883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.